ZCM
RVLP

Zebra Capital Management’s RVL Pharmaceuticals plc Ordinary Shares RVLP Stock Holding History

Zebra Capital Management’s Portfolio RVLP Stock Details RVLP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-24,384
Closed -$26K – 188
2021
Q4 		$26K Hold
24,384
– – 0.04% 154
2021
Q3 		$72K Hold
24,384
– – 0.09% 178
2021
Q2 		$73K Hold
24,384
– – 0.09% 159
2021
Q1 		$79K Buy
+24,384
New +$100K 0.09% 167

Other funds holding RVLP

ACM
Athyrium Capital Management New York $8.69M AUM 34.58% 1-Year Est. Return
RA
Rovida Advisors Fort Lauderdale, Florida $116M AUM 12.52% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
MWM
Marietta Wealth Management Marietta, Georgia $841M AUM 21.92% 1-Year Est. Return
TC
Titleist Capital San Antonio, Texas $427M AUM 24.17% 1-Year Est. Return

Zebra Capital Management's RVLP Position: Q1 2022 in Review

Zebra Capital Management sold out of RVL Pharmaceuticals plc Ordinary Shares (RVLP) in Q1 2022, closing a stake of 24,384 shares — an estimated $26K sold.

Zebra Capital Management first reported a position in RVLP in Q1 2021 and held it in 4 quarters. The position peaked at $79K in Q1 2021. 36 funds tracked by Wall St. Rank hold RVLP as of Q1 2022.

  • Zebra Capital Management reported no remaining RVL Pharmaceuticals plc Ordinary Shares position as of Q1 2022 after selling out during the quarter.
  • Zebra Capital Management sold 24,384 RVL Pharmaceuticals plc Ordinary Shares shares in Q1 2022, an estimated $26K.
  • Zebra Capital Management first reported a position in RVL Pharmaceuticals plc Ordinary Shares in Q1 2021 and held it in 4 quarters.
  • Zebra Capital Management's RVL Pharmaceuticals plc Ordinary Shares position peaked at $79K in Q1 2021.
  • 36 funds tracked by Wall St. Rank held RVL Pharmaceuticals plc Ordinary Shares as of Q1 2022.

Based on Zebra Capital Management's 13F filing for Q1 2022, filed 16 May 2022.